Literature DB >> 9550873

The functional consequences of airway remodeling in asthma.

P D Paré1, C R Roberts, T R Bai, B J Wiggs.   

Abstract

Structural changes in the airway walls involving extracellular matrix remodelling are prominent features of asthma. These changes are probably driven by mediators released as a consequence of chronic allergic inflammation. It is clear that changes in the extracellular matrix have the capacity to influence airway function in asthma. However, it is not clear how each of the many changes that occur in the airway wall contribute to altered airway function in asthma. Collagen deposition in the subepithelial matrix, and hyaluronan and versican deposition around and internal to the smooth muscle would be expected to oppose the effect of smooth muscle contraction. Conversely, geometric considerations would result in exaggerated airway narrowing for a given degree of smooth muscle shortening, as the airway wall is thickened by the deposition of these molecules internal to the smooth muscle. Elastin and cartilage reorganization and degradation in the airway walls would be expected to result in decreased airway wall stiffness and increased airway narrowing for a given amount of force generated by the smooth muscle. Degradation of matrix associated with the smooth muscle may both decrease the stiffness of the parallel elastic component and uncouple smooth muscle from the load provided by lung recoil, allowing exaggerated smooth muscle shortening. Increase in muscle mass may be associated with an increase, a decrease or no change in smooth muscle contractility. If an increase in muscle mass was associated with preservation of its contractile capacity modelling studies suggest that it could be the most important contributor to exaggerated airway narrowing. Modelling studies also suggest that the pattern of mucosal folding during smooth muscle contraction may be an important determinant of airway narrowing. The greater the number of folds, and the stiffer the subepithelial collagenous layer the more resistant the airway will be to narrowing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9550873

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  21 in total

Review 1.  Airway remodeling in asthma.

Authors:  J A Elias; Z Zhu; G Chupp; R J Homer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Regulator of G-protein signaling 2 repression exacerbates airway hyper-responsiveness and remodeling in asthma.

Authors:  Haihong Jiang; Yan Xie; Peter W Abel; Dennis W Wolff; Myron L Toews; Reynold A Panettieri; Thomas B Casale; Yaping Tu
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 3.  Pharmacotherapy and airway remodelling in asthma?

Authors:  P A Beckett; P H Howarth
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 4.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 5.  Airway smooth muscle and bronchospasm: fluctuating, fluidizing, freezing.

Authors:  Ramaswamy Krishnan; Xavier Trepat; Trang T B Nguyen; Guillaume Lenormand; Madavi Oliver; Jeffrey J Fredberg
Journal:  Respir Physiol Neurobiol       Date:  2008-04-20       Impact factor: 1.931

6.  Force maintenance and myosin filament assembly regulated by Rho-kinase in airway smooth muscle.

Authors:  Bo Lan; Linhong Deng; Graham M Donovan; Leslie Y M Chin; Harley T Syyong; Lu Wang; Jenny Zhang; Christopher D Pascoe; Brandon A Norris; Jeffrey C-Y Liu; Nicholas E Swyngedouw; Saleha M Banaem; Peter D Paré; Chun Y Seow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-10       Impact factor: 5.464

7.  Effect of tumor suppressor PTEN gene on apoptosis and cell cycle of human airway smooth muscle cells.

Authors:  Liang Luo; Yuan Qi Gong; Xiefei Qi; Wenyan Lai; Haibing Lan; Yaling Luo
Journal:  Mol Cell Biochem       Date:  2012-12-29       Impact factor: 3.396

Review 8.  Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases.

Authors:  Khuder Alagha; Alain Palot; Tunde Sofalvi; Laurie Pahus; Marion Gouitaa; Celine Tummino; Stephanie Martinez; Denis Charpin; Arnaud Bourdin; Pascal Chanez
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

Review 9.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

10.  Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason?

Authors:  Madavi N Oliver; Ben Fabry; Aleksandar Marinkovic; Srboljub M Mijailovich; James P Butler; Jeffrey J Fredberg
Journal:  Am J Respir Cell Mol Biol       Date:  2007-04-26       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.